Why the study?
Non-antithrombin-mediated causes of heparin resistance are generally poorly characterized and less prevalent in the literature.
Highlights rare non-antithrombin-mediated causes of heparin resistance (paraproteinemia and hyperfibrinogenemia) during cardiac surgery and the challenges of managing anticoagulation for cardiopulmonary bypass.
Paraproteinemia and hyperfibrinogenemia should be considered in unexplained heparin resistance during cardiac surgery; leaves open systematic characterization of non-AT mechanisms.
It is well known that antithrombin (AT) deficiency results in decreased heparin sensitivity, also known as "heparin resistance." However, non-AT-mediated causes of heparin resistance are generally poorly characterized and less prevalent in the literature. We present 2 case reports of non-AT-mediated heparin resistance during cardiac surgery due to paraproteinemia and hyperfibrinogenemia. These cases highlight the challenges posed by unusual conditions in achieving adequate anticoagulation for cardiopulmonary bypass (CPB). The pros and cons of the treatment selections for these cases are discussed, and the potential complications of large doses of unfractionated heparin are considered.
No takes yet. Share an insight, caveat, or question.
Edwards et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: